A SYNTHETIC CHIMERIC FUSION PROTEIN WITH IMMUNO-THERAPEUTIC USES

摘要

The present invention relates to an immuno-therapy conjugate which comprises A-c-B wherein: A and B are different and are compoun ds selected from the group consisting of cytokines, chemokines, interferons, their respective receptors or a functional fragment thereof; andc is a linker consisting of a bond or an amino acid sequence containing from 1 to 100 residues. The present invention also relates to a vaccine adjuvant comprising the immuno-therapy conjugate of the present invention. The present invention further relates to a method of reducing tumor growth, for inhibiting a viral infection and for improving immune response in a patient.